These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 22017171)
1. Sarcoid intermediate uveitis following etanercept treatment: a case report and review of the literature. Fonollosa A; Artaraz J; Les I; Martinez-Berriotxoa A; Izquierdo JP; Lopez AS; Gardeazaba J; Berasategui B; Martinez-Alday N Ocul Immunol Inflamm; 2012 Feb; 20(1):44-8. PubMed ID: 22017171 [TBL] [Abstract][Full Text] [Related]
2. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review. Massara A; Cavazzini L; La Corte R; Trotta F Semin Arthritis Rheum; 2010 Feb; 39(4):313-9. PubMed ID: 19147181 [TBL] [Abstract][Full Text] [Related]
5. Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists. Lamrock E; Brown P Australas J Dermatol; 2012 Nov; 53(4):e87-90. PubMed ID: 23157794 [TBL] [Abstract][Full Text] [Related]
6. [The treatment of recurrent uveitis with TNF-alpha inhibitors]. Falappone PC; Iannone F; Scioscia C; Grattagliano V; Covelli M; Lapadula G Reumatismo; 2004; 56(3):185-9. PubMed ID: 15470524 [TBL] [Abstract][Full Text] [Related]
7. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis]. Haake H; Köneke J; Amann K; vom Dahl J; Janssen U Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969 [TBL] [Abstract][Full Text] [Related]
10. Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents. Saurenmann RK; Levin AV; Feldman BM; Laxer RM; Schneider R; Silverman ED J Pediatr; 2006 Dec; 149(6):833-6. PubMed ID: 17137902 [TBL] [Abstract][Full Text] [Related]
11. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions]. Paul C; Solignac M Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165 [No Abstract] [Full Text] [Related]
12. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Galor A; Perez VL; Hammel JP; Lowder CY Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615 [TBL] [Abstract][Full Text] [Related]
13. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment. Kakkassery V; Mergler S; Pleyer U Curr Eye Res; 2010 Aug; 35(8):751-6. PubMed ID: 20673052 [TBL] [Abstract][Full Text] [Related]
14. Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature. Taban M; Dupps WJ; Mandell B; Perez VL Ocul Immunol Inflamm; 2006 Jun; 14(3):145-50. PubMed ID: 16766397 [TBL] [Abstract][Full Text] [Related]
15. Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-alpha antagonists. Gottlieb GS; Lesser CF; Holmes KK; Wald A Clin Infect Dis; 2003 Sep; 37(6):838-40. PubMed ID: 12955647 [TBL] [Abstract][Full Text] [Related]